| Finding | Assessment |
|---|---|
| 5-Year Stock Return | Stock currently $479, up 74% from $276 (5 years ago). TTM OP grew from ~$770M to $3,699M; P/E ranged 31x-65x across the period, now 34x as restated higher OP/NP brings the multiple back inside pre-Ansys norms. Forward P/E ~32x. |
| Business Model | Synopsys is the #1 EDA + IP vendor and, with Ansys, global leader in engineering solutions from silicon to systems. Three segments (EDA 51%, Design IP 20%, Ansys 29% in Q2 FY26) with $11B backlog and ratable license model. |
| Competitive Moat | WIDE Deep foundry co-optimization, mission-critical design tools with high switching costs, broadest IP portfolio across foundries, agentic AI + Multiphysics Fusion. Ansys adds system-level simulation leadership. |
| Past 5-YR Drivers | AI-driven semiconductor complexity, Ansys acquisition scaling revenue and margins, hardware verification record growth, advanced-node leadership at 2nm and below. Non-GAAP OM expanding from 37.3% (FY25) to 41% guided (FY26). |
| Recent Stock Move | Stock currently $479, vs. $396 Q2'26 close (+21% post last quarter end). Q2 beat + raised FY guide + Elliott deal + Multiphysics Fusion commercial ramp signal drove the rip. Forward P/E ~32x on FY26 midpoint EPS. |
| Revenue Trend | DECELERATING Rev YoY: 42% (Q2 2026) → 40% (Q3 2026E). |
| Margin Trend | FLAT OM%: 40% (Q2 2026) → 40% (Q3 2026E). |
| TTM OP Trajectory | FLAT TTM OP QoQ: +9% (Q2 2026) → +9% (Q3 2026E). TTM OP $3,699M. |
| Key Opportunities | Multiphysics Fusion commercial ramp 2H FY26 → $400M FY27 revenue synergies. IP new monetization model (subscription+consumption) with hyperscaler COT customers. Agentic AI consumption-based pricing layer. Intel 18A/14A pipeline = IP upside not in FY26 guide. |
| Key Risks | Elevated leverage ($10B debt, 3.2x Debt/EBITDA) limits financial flexibility. China design starts constrained by export controls + domestic competitors. Analog/industrial design starts muted (only AI growing). FY27 Multiphysics Fusion monetization is the swing factor. |
| Catalysts | Q3 FY26 guide $2.41-2.46B revenue and non-GAAP EPS $3.63-3.69. Investor Day Sep 30, 2026 with long-term framework + Multiphysics Fusion monetization plan. Processor IP divestiture closing shortly. Multiphysics Fusion commercial ramp 2H FY26. Intel 18A/14A IP ramp 2027. |
| P/E(ttm) Valuation | P/E(ttm) at 34x after the historical OP/NP restatement now sits inside the pre-Ansys 31x-65x range. On FY26 non-GAAP midpoint EPS $14.76, forward P/E is ~32x — premium that prices in 40% non-GAAP OM + FY27 Multiphysics Fusion monetization. Successful execution could support 30x-40x forward sustained. |
| Segment | Revenue | % of Total | Key Details |
|---|---|---|---|
| EDA | $1,162M | 51.0% | +8% organic YoY. Digital + custom IC design, verification HW (ZeBu, HAPS-200, ZS5), AI-driven EDA. 30+ full-flow advanced-node wins in Q2. |
| Design IP | $454M | 20.0% | -6% YoY but +12% QoQ — bottomed Q1. PCIe 7.0 >90% win rate, 18 new licenses; UCIE 150+ lifetime wins; first HBM4 IP test chip. Processor IP divestiture closing shortly. |
| Ansys | $652M | 28.7% | Includes $12.5M Q2 channel-gross-up. Multiphysics simulation across semis + industrial + auto + A&D. FY26 Ansys revenue ~$2.96B; Multiphysics Fusion ramps 2H FY26. |
| Other | $7M | 0.3% | University programs, mechatronics, FX hedge impact. Optical Solutions Group divested Oct 2025. |
Internal R&D ($2.5B/yr)
Foundry partnerships (TSMC, Samsung, Intel)
Academic research
Open-source IP standards bodies
EDA software (ratable licenses)
Design IP (per-design + royalties)
Multi-physics simulation (Ansys)
Hardware verification (ZeBu, HAPS)
$11B backlog
Semiconductor companies (NVIDIA, AMD)
Hyperscalers (custom AI silicon / COT)
Foundries (TSMC, Samsung, Intel)
Automotive & aerospace OEMs
Industrial & energy companies
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026E | |
|---|---|---|---|---|---|---|---|---|---|---|
| Quarter End | Apr 2024 | Jul 2024 | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
| Stock Price | $572 | $595 | $506 | $485 | $429 | $513 | $493 | $470 | $396 | $479 |
| Stock QoQ | +11% | +4% | -15% | -4% | -12% | +20% | -4% | -5% | -16% | +21% |
| Rev YoY | 15% | 13% | 12% | -4% | 10% | 14% | 38% | 66% | 42% | 40% |
| OM% | 37% | 40% | 37% | 36% | 38% | 39% | 36% | 42% | 40% | 40% |
| R40 (Rev YoY + OM%) | 53% | 53% | 48% | 33% | 48% | 53% | 74% | 108% | 81% | 79% |
| TTM OP ($M) | $2,188 | $2,306 | $2,362 | $2,288 | $2,353 | $2,412 | $2,631 | $3,114 | $3,406 | $3,699 |
| TTM OP QoQ | +5% | +5% | +2% | -3% | +3% | +3% | +9% | +18% | +9% | +9% |
| FCF/OP ttm | 50% | 43% | 54% | 57% | 46% | 54% | 51% | 73% | 77% | 74% |
| Debt/EBITDA | 0.3x | 0.3x | 0.3x | 0.3x | 4.6x | 6.3x | 5.4x | 3.5x | 3.2x | 3.2x |
| P/E ttm | 46x | 45x | 38x | 38x | 32x | 39x | 43x | 38x | 31x | 34x |
| Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Q4'23 | Q1'24 | Q2'24 | Q3'24 | Q4'24 | Q1'25 | Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26E | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quarter End | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | Jul24 | Oct24 | Jan25 | Apr25 | Jul25 | Oct25 | Jan26 | Apr26 | Jul26 |
| R40 > 40% | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ||||||
| R40 accelerate | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | |||||||||
| TTM OP QoQ > 10% | ✅ | ✅ | ✅ | ✅ | ✅ | |||||||||||||||
| TTM OP QoQ accelerate | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | |||||||||||
| TTM FCF/OP > 60% | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ✅ | ✅ | ✅ |
| Debt/EBITDA < 3.5 | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ❌ | ❌ | ❌ | ✅ | ✅ | ✅ |
| Total passes | 4 | 6 | 4 | 2 | 2 | 4 | 2 | 6 | 6 | 4 | 2 | 4 | 2 | 1 | 3 | 2 | 3 | 6 | 3 | 3 |
| Stock QoQ | +8% | +23% | -10% | -9% | +1% | +4% | +21% | +13% | +6% | +12% | +11% | +4% | -15% | -4% | -12% | +20% | -4% | -5% | -16% | +21% |
| P/E ttm | 65x | 62x | 45x | 37x | 35x | 35x | 42x | 44x | 41x | 42x | 46x | 45x | 38x | 38x | 32x | 39x | 43x | 38x | 31x | 34x |